Themis Medicare Ltd

Themis Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Feb 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Themis Medicare Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.73.63 today, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in both its financial performance and market sentiment.

Themis Medicare Ltd has reached a new 52-week low of Rs.73.79 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and market valuation.

Themis Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Feb 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 09 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market standing.

Themis Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 February 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Themis Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 February 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 14 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.

Themis Medicare Ltd recorded a robust intraday performance on 3 Feb 2026, surging 7.03% to touch a day’s high of Rs 84.99, significantly outperforming its sector and the broader market amid mixed market conditions.

Themis Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 February 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Themis Medicare Ltd witnessed a robust start to the trading session on 3 Feb 2026, opening with a notable gap up of 9.59%, signalling renewed positive momentum after two consecutive days of decline. This surge outpaced the Pharmaceuticals & Biotechnology sector’s gain of 2.73%, underscoring a distinct shift in market sentiment towards the stock.

Themis Medicare Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.76 today, marking a significant decline in its stock price amidst ongoing downward momentum and underperformance relative to the broader market and sector indices.

Themis Medicare Ltd commenced trading with a significant gap up, opening 6.85% higher than its previous close, signalling a robust start amid positive market sentiment. This upward move outpaced the Pharmaceuticals & Biotechnology sector by 2.86%, marking a notable shift after two consecutive days of decline.

Themis Medicare Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.77.15 today, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices.

Themis Medicare Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.78.7 today, marking a significant decline in its stock price amid ongoing financial headwinds and subdued market performance.

Themis Medicare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 15 February 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Themis Medicare Ltd’s shares declined sharply to a fresh 52-week low of Rs.79.05 on 21 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed its sector and broader market indices, reflecting persistent financial pressures and subdued sales performance over recent quarters.

Themis Medicare Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.85 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing financial pressures and subdued performance metrics.